1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Tablets
  • 1.2.3 Capsule
  • 1.2.4 Lozenge
  • 1.2.5 Powder
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Share by Application: 2020 VS 2026
  • 1.3.2 Instant Release
  • 1.3.3 Sustained Release
  • 1.3.4 Extended Release
  • 1.3.5 Effervescent Tablets
  • 1.3.6 Chewable Tablets
  • 1.3.7 Enteric Release
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Perspective (2015-2026)
• 2.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Growth Trends by Regions
  • 2.2.1 Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmaceutical Solid Dosage Contract Manufacturing Players by Market Size
  • 3.1.1 Global Top Pharmaceutical Solid Dosage Contract Manufacturing Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Players (2015-2020)
• 3.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Pharmaceutical Solid Dosage Contract Manufacturing Revenue
• 3.4 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Concentration Ratio
  • 3.4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Solid Dosage Contract Manufacturing Revenue in 2019
• 3.5 Key Players Pharmaceutical Solid Dosage Contract Manufacturing Area Served
• 3.6 Key Players Pharmaceutical Solid Dosage Contract Manufacturing Product Solution and Service
• 3.7 Date of Enter into Pharmaceutical Solid Dosage Contract Manufacturing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Solid Dosage Contract Manufacturing Breakdown Data by Type (2015-2026)

• 4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Solid Dosage Contract Manufacturing Breakdown Data by Application (2015-2026)

• 5.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Application (2015-2020)
• 5.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2015-2026)
• 6.2 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Type (2015-2020)
• 6.3 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Application (2015-2020)
• 6.4 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2015-2026)
• 7.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Type (2015-2020)
• 7.3 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Application (2015-2020)
• 7.4 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2015-2026)
• 8.2 China Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Type (2015-2020)
• 8.3 China Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Application (2015-2020)
• 8.4 China Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2015-2026)
• 9.2 Japan Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Type (2015-2020)
• 9.3 Japan Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Application (2015-2020)
• 9.4 Japan Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2015-2026)
• 10.2 Southeast Asia Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Type (2015-2020)
• 10.3 Southeast Asia Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Application (2015-2020)
• 10.4 Southeast Asia Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.1.4 Abbott Laboratories Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020))
  • 11.1.5 Abbott Laboratories Recent Development
• 11.2 Catalent Pharma Solutions
  • 11.2.1 Catalent Pharma Solutions Company Details
  • 11.2.2 Catalent Pharma Solutions Business Overview
  • 11.2.3 Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.2.4 Catalent Pharma Solutions Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.2.5 Catalent Pharma Solutions Recent Development
• 11.3 Jubilant Life Sciences Limited
  • 11.3.1 Jubilant Life Sciences Limited Company Details
  • 11.3.2 Jubilant Life Sciences Limited Business Overview
  • 11.3.3 Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.3.4 Jubilant Life Sciences Limited Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.3.5 Jubilant Life Sciences Limited Recent Development
• 11.4 Alkermes
  • 11.4.1 Alkermes Company Details
  • 11.4.2 Alkermes Business Overview
  • 11.4.3 Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.4.4 Alkermes Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.4.5 Alkermes Recent Development
• 11.5 BioPharma Solutions
  • 11.5.1 BioPharma Solutions Company Details
  • 11.5.2 BioPharma Solutions Business Overview
  • 11.5.3 BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.5.4 BioPharma Solutions Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.5.5 BioPharma Solutions Recent Development
• 11.6 Cytovance Biologics
  • 11.6.1 Cytovance Biologics Company Details
  • 11.6.2 Cytovance Biologics Business Overview
  • 11.6.3 Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.6.4 Cytovance Biologics Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.6.5 Cytovance Biologics Recent Development
• 11.7 DPT Laboratories
  • 11.7.1 DPT Laboratories Company Details
  • 11.7.2 DPT Laboratories Business Overview
  • 11.7.3 DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.7.4 DPT Laboratories Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.7.5 DPT Laboratories Recent Development
• 11.8 Fresenius Kabi
  • 11.8.1 Fresenius Kabi Company Details
  • 11.8.2 Fresenius Kabi Business Overview
  • 11.8.3 Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.8.4 Fresenius Kabi Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.8.5 Fresenius Kabi Recent Development
• 11.9 Halo Pharmaceutical
  • 11.9.1 Halo Pharmaceutical Company Details
  • 11.9.2 Halo Pharmaceutical Business Overview
  • 11.9.3 Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.9.4 Halo Pharmaceutical Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.9.5 Halo Pharmaceutical Recent Development
• 11.10 Lyophilization Technology
  • 11.10.1 Lyophilization Technology Company Details
  • 11.10.2 Lyophilization Technology Business Overview
  • 11.10.3 Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 11.10.4 Lyophilization Technology Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 11.10.5 Lyophilization Technology Recent Development
• 11.11 Mikart
  • 10.11.1 Mikart Company Details
  • 10.11.2 Mikart Business Overview
  • 10.11.3 Mikart Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 10.11.4 Mikart Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 10.11.5 Mikart Recent Development
• 11.12 Pillar5 Pharma
  • 10.12.1 Pillar5 Pharma Company Details
  • 10.12.2 Pillar5 Pharma Business Overview
  • 10.12.3 Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 10.12.4 Pillar5 Pharma Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 10.12.5 Pillar5 Pharma Recent Development
• 11.13 Haupt Pharma
  • 10.13.1 Haupt Pharma Company Details
  • 10.13.2 Haupt Pharma Business Overview
  • 10.13.3 Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 10.13.4 Haupt Pharma Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 10.13.5 Haupt Pharma Recent Development
• 11.14 Althea Technologies
  • 10.14.1 Althea Technologies Company Details
  • 10.14.2 Althea Technologies Business Overview
  • 10.14.3 Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 10.14.4 Althea Technologies Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 10.14.5 Althea Technologies Recent Development
• 11.15 Associates of Cape Cod
  • 10.15.1 Associates of Cape Cod Company Details
  • 10.15.2 Associates of Cape Cod Business Overview
  • 10.15.3 Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 10.15.4 Associates of Cape Cod Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 10.15.5 Associates of Cape Cod Recent Development
• 11.16 Covance
  • 10.16.1 Covance Company Details
  • 10.16.2 Covance Business Overview
  • 10.16.3 Covance Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 10.16.4 Covance Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 10.16.5 Covance Recent Development
• 11.17 Emergent BioSolutions
  • 10.17.1 Emergent BioSolutions Company Details
  • 10.17.2 Emergent BioSolutions Business Overview
  • 10.17.3 Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Introduction
  • 10.17.4 Emergent BioSolutions Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2015-2020)
  • 10.17.5 Emergent BioSolutions Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Pharmaceutical Solid Dosage Contract Manufacturing Scope and Market Size
Pharmaceutical Solid Dosage Contract Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Solid Dosage Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Tablets
Capsule
Lozenge
Powder
Others

Market segment by Application, split into
Instant Release
Sustained Release
Extended Release
Effervescent Tablets
Chewable Tablets
Enteric Release

Based on regional and country-level analysis, the Pharmaceutical Solid Dosage Contract Manufacturing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Solid Dosage Contract Manufacturing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Abbott Laboratories
Catalent Pharma Solutions
Jubilant Life Sciences Limited
Alkermes
BioPharma Solutions
Cytovance Biologics
DPT Laboratories
Fresenius Kabi
Halo Pharmaceutical
Lyophilization Technology
Mikart
Pillar5 Pharma
Haupt Pharma
Althea Technologies
Associates of Cape Cod
Covance
Emergent BioSolutions